Immutep Ltd Files Routine 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Dec 17, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Dec 17, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, routine-report, pharmaceutical
Related Tickers: IMMP
TL;DR
Immutep Ltd (IMMP) filed a standard 6-K, nothing major but shows they're active.
AI Summary
Immutep Limited filed a Form 6-K on December 17, 2025, reporting as of December 16, 2025. The company, formerly known as Prima BioMed Ltd, is a pharmaceutical preparations company based in Sydney, Australia. This filing is a routine report for a foreign private issuer.
Why It Matters
This filing indicates ongoing compliance and reporting by Immutep Limited, a company operating in the pharmaceutical sector. Investors can monitor these reports for updates on the company's status.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain significant new financial or operational information that would inherently increase risk.
Key Numbers
- 001-35428 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- IMMUTEP Ltd (company) — Filer
- Prima BioMed Ltd (company) — Former company name
- 001-35428 (dollar_amount) — SEC File Number
- 20251216 (date) — Report date
- 20251217 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC whenever the issuer publicly releases or makes available to shareholders information that it would be required to file with its home country's securities commission.
What was Immutep Limited's former name?
Immutep Limited was formerly known as Prima BioMed Ltd.
When was this Form 6-K filed?
This Form 6-K was filed on December 17, 2025.
What is Immutep Limited's primary business sector?
Immutep Limited is in the Pharmaceutical Preparations sector, SIC code 2834.
Where is Immutep Limited's principal executive office located?
Immutep Limited's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Filing Stats: 263 words · 1 min read · ~1 pages · Grade level 17.5 · Accepted 2025-12-16 19:47:22
Filing Documents
- d31816d6k.htm (6-K) — 10KB
- d31816dex991.htm (EX-99.1) — 12KB
- g31816snap1.jpg (GRAPHIC) — 7KB
- g31816snap2.jpg (GRAPHIC) — 10KB
- 0001193125-25-321340.txt ( ) — 46KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 16, 2025 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer